With targeted drugs, smart drugs, and nanotechnology enering our lives, drug design in the coming years will evolve in a completely different direction. While DNA-based nano-robots offer great promise in the treatment of cancer, artificial intelligence and wearable technologies are to be seen in the near future.
Giving information on developments to be experienced in drug design in the coming years, Prof. Dr. Meriç Köksal Akkoç of the Faculty of Pharmacy of Yeditepe University, emphasized that more reliable, more effective and higher quality work in drug design in parallel with technological developments has started.
DNA Nano-Robots
Prof. Dr. Meriç Köksal Akkoç explained that the development of DNA-based nano-robots was planned within the scope of targeted drug studies, emphasizing that the side effects are reduced while increasing drug efficiency with targeted / intelligent treatment systems.
Prof. Dr. Meriç Köksal Akkoç, said: “New studies and results have shown that DNA-based nano-robotic systems have much higher activity and selectivity than previously agreed treatments.
It is known that DNA nano-robots can be successful in specifically targeted tumor treatment. In addition, cancer immunotherapy research can reduce systemic toxicity while increasing response to anti-tumor treatments.“
Recognizing that technological developments have created medicine candidates with potency to be effective, Akkoç noted that they provide profit in both academic and industrial drug research in terms of time and cost.
Protective Treatment Will Become Easier
Prof. Dr. Meriç Köksal Akkoç also pointed out that in drug researches called “Pharma 4.0”, many applications such as artificial intelligence, wearable technologies, body sensors etc. will be effective in the fast and reliable patients’ treatment and will also serve to facilitate technological developments in preventive health care (prophylaxis).
